RBP4 interferes with tongue squamous cell carcinoma progression by inhibiting the PI3K/AKT signaling pathway and

Ying Yan1, Nan Miao1, Xiaofeng Wang2

  • 1Department of Stomatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Scientific Reports
|February 16, 2026
PubMed

Insights

Retinol-binding protein 4 (RBP4) inhibits tongue squamous cell carcinoma (TSCC) growth by reducing tumor cell proliferation and promoting anti-tumor M1 macrophage polarization. This study reveals RBP4 as a potential therapeutic target for TSCC.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tongue squamous cell carcinoma (TSCC) significantly impacts patient quality of life, necessitating novel therapeutic strategies.
  • Understanding the molecular mechanisms driving TSCC progression and immune evasion is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role and mechanism of retinol-binding protein 4 (RBP4) in TSCC progression.
  • To determine RBP4's effect on tumor-associated macrophage (TAM) polarization and its impact on TSCC growth.

Main Methods:

  • TSCC cell lines with altered RBP4 expression (overexpression and knockdown) were created.
  • Ex vivo experiments assessed RBP4's impact on TSCC cell proliferation and invasion.
  • A co-culture model examined RBP4's influence on macrophage polarization via NF-κB and PI3K/Akt/mTOR signaling pathways.

Main Results:

  • RBP4 overexpression inhibited TSCC cell proliferation and epithelial-mesenchymal transition by reducing PI3K/Akt/mTOR pathway phosphorylation and regulating Snail levels.
  • RBP4 promoted M1-type polarization of tumor-associated macrophages through NF-κB pathway activation.
  • RBP4 demonstrated antitumor effects by inhibiting TSCC growth and migration.

Conclusions:

  • RBP4 inhibits TSCC cell proliferation and migration by suppressing the PI3K-Akt signaling pathway.
  • RBP4 promotes M1-type polarization of TAMs, contributing to their antitumor activity.
  • RBP4 represents a promising therapeutic target for tongue squamous cell carcinoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K